|
|
Article: Xcorporeal, Inc. Reports on Failure to Meet Listing Standards of NYSE Amex LLC.
- Article from:
- Blood Weekly
- Article date:
- June 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Xcorporeal, Inc. (NYSE Amex: XCR) (the "Company" or "Xcorporeal") announced that on May 15, 2009, the Company received notice from the staff of the NYSE Amex LLC (formerly American Stock Exchange, the "Exchange") indicating that the Company is currently not in compliance with certain of the Exchange's continued listing standards as set forth in Section 1003(a)(iv) of the Exchange's Company Guide (the "Company Guide"). According to the notice, the Company is not in compliance in that it has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it ...